Honorio KM - Search Results

1

Structural Dynamics of DPP-4 and Its Influence on the Projection of Bioactive Ligands.

Pantaleão SQ, Philot EA, de Resende-Lara PT, Lima AN, Perahia D, Miteva MA, Scott AL, Honorio KM. Pantaleão SQ, et al. Among authors: honorio km. Molecules. 2018 Feb 23;23(2):490. doi: 10.3390/molecules23020490. Molecules. 2018. PMID: 29473857 Free PMC article.

2

Identification of electronic and structural descriptors of adenosine analogues related to inhibition of leishmanial glyceraldehyde-3-phosphate dehydrogenase.

Lozano NB, Oliveira RF, Weber KC, Honorio KM, Guido RV, Andricopulo AD, Da Silva AB. Lozano NB, et al. Among authors: honorio km. Molecules. 2013 Apr 29;18(5):5032-50. doi: 10.3390/molecules18055032. Molecules. 2013. PMID: 23629757 Free PMC article.

3

Identifying structural features related to the biological activity of a series of AT1 antagonists from fragment-based drug design.

da C Silva D, Maltarollo VG, Honorio KM. da C Silva D, et al. Among authors: honorio km. Protein Pept Lett. 2014 Jun;21(6):542-9. doi: 10.2174/092986652106140425122007. Protein Pept Lett. 2014. PMID: 24779772

4

Molecular docking studies and 2D analyses of DPP-4 inhibitors as candidates in the treatment of diabetes.

Pantaleão SQ, Maltarollo VG, Araujo SC, Gertrudes JC, Honorio KM. Pantaleão SQ, et al. Among authors: honorio km. Mol Biosyst. 2015 Nov;11(11):3188-93. doi: 10.1039/c5mb00493d. Mol Biosyst. 2015. PMID: 26399297

5

In silico studies on the interaction between bioactive ligands and ALK5, a biological target related to the cancer treatment.

Almeida MO, Trossini GH, Maltarollo VG, Silva Dda C, Honorio KM. Almeida MO, et al. Among authors: honorio km. J Biomol Struct Dyn. 2016 Sep;34(9):2045-53. doi: 10.1080/07391102.2015.1106340. Epub 2016 Mar 8. J Biomol Struct Dyn. 2016. PMID: 26524124

6

Use of machine learning approaches for novel drug discovery.

Lima AN, Philot EA, Trossini GH, Scott LP, Maltarollo VG, Honorio KM. Lima AN, et al. Among authors: honorio km. Expert Opin Drug Discov. 2016;11(3):225-39. doi: 10.1517/17460441.2016.1146250. Expert Opin Drug Discov. 2016. PMID: 26814169 Review.

7

Advances and Challenges in Drug Design of PPARδ Ligands.

Maltarollo VG, Kronenberger T, Windshugel B, Wrenger C, Trossini GHG, Honorio KM. Maltarollo VG, et al. Among authors: honorio km. Curr Drug Targets. 2018;19(2):144-154. doi: 10.2174/1389450118666170414113159. Curr Drug Targets. 2018. PMID: 28413978 Review.

8

The Role of QSAR and Virtual Screening Studies in Type 2 Diabetes Drug Discovery.

Pantaleao SQ, Fujii DGV, Maltarollo VG, da C Silva D, Trossini GHG, Weber KC, Scott LPB, Honorio KM. Pantaleao SQ, et al. Among authors: honorio km. Med Chem. 2017;13(8):706-720. doi: 10.2174/1573406413666170522152102. Med Chem. 2017. PMID: 28530546 Review.

9

Computational analyses of interactions between ALK-5 and bioactive ligands: insights for the design of potential anticancer agents.

Almeida MO, Costa CHS, Gomes GC, Lameira J, Alves CN, Honorio KM. Almeida MO, et al. Among authors: honorio km. J Biomol Struct Dyn. 2018 Nov;36(15):4010-4022. doi: 10.1080/07391102.2017.1404938. Epub 2017 Nov 28. J Biomol Struct Dyn. 2018. PMID: 29132261

10

UDP-glucuronosyltransferases: Structure, Function and Drug Design Studies.

Mano ECC, Scott AL, Honorio KM. Mano ECC, et al. Among authors: honorio km. Curr Med Chem. 2018;25(27):3247-3255. doi: 10.2174/0929867325666180226111311. Curr Med Chem. 2018. PMID: 29484974 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page